Theravance Biopharma (TBPH) PT Lowered to $10 at BofA Securities
Tweet
Share
E-mailGet Alerts TBPH Hot Sheet
Price: $16.97 --0%
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 14
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 14
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Theravance Biopharma (NASDAQ: TBPH) to $10.00 (from $11.00) while maintaining a Underperform rating.
You May Also Be Interested In
- JD.com, Inc (JD) PT Lowered to $30 at Susquehanna
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK340 at JPMorgan
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
